Verily Life Sciences

Dallas, Texas [1, 3, 4, 15, 17]  All United States companies → — Founded 2015
Clinical AI Platform Healthcare Analytics / BI Wearables / RPM
Cardiology Family Medicine Internal Medicine Neurology
Cardiology AI Wearables & Remote Monitoring (RPM)
Late-stage / Private Equity (as of May 2026, the company is at a late growth stage and has converted to a corporation) [19, 23]

Products

Study Watch with Irregular Pulse Monitor (Home)
Verily Health
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Study Watch
Verily
Cardiology AI
Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Study Watch with Irregular Pulse Monitor
Verily Life Sciences
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor is an FDA-cleared, prescription-only wearable device from Verily Life Sciences. It is designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.

See all 3 products →

About Verily Life Sciences

Verily Life Sciences, now officially known as Verily Health Inc. as of March 2026, is a precision health company that originated as a “moonshot” project within Google X in 2015. It operates at the intersection of biology, data science, and engineering, aiming to transform healthcare by making health data actionable to improve global health outcomes. The company’s mission is to enable people to lead healthier lives by leveraging advanced technology to understand health better and develop tools for early diagnosis and more effective treatments. [2, 12, 17, 24]

Verily serves a diverse range of clients, including healthcare systems, researchers, pharmaceutical companies, and patients. Its integrated platform combines technology, data science, and clinical expertise to generate high-fidelity evidence and utilize advanced digital measurement devices. Verily’s core offerings address challenges in care delivery, clinical research, and public health by integrating disparate data sources such as clinical trials, electronic health records, wearable device data, and wastewater pathogen tracking. This comprehensive approach facilitates better diagnosis, monitoring, and treatment decisions. [2, 13, 17]

Focus Areas

Precision health AI-driven healthcare solutions Clinical research Advanced healthcare analytics Chronic disease management Real-world evidence generation Data harmonization AI model development Digital precision medicine Public health pathogen tracking

Business Intelligence

TechnologyAI-native platform, Verily Pre platform, Refinery (health data harmonization), Exchange, Workbench (multi-modal data analysis, secure analytics environment), Baseline platform (clinical trial system and evidence generation), Verily Intelligence

What Physicians Need to Know

Precision Health AI Platforms
Verily specializes in AI-native precision health platforms that build, validate, and deploy AI models and agents for research and care workflows. Their Pre platform harmonizes fragmented clinical information into FHIR-native, AI-ready datasets.
Clinical Research & Real-World Evidence
Verily offers end-to-end solutions for clinical trial management and operations, including digital biomarker and wearable sensing programs. They focus on real-world data curation and evidence generation, transforming traditional research into dynamic, ongoing conversations with engaged participants.
Chronic Disease Management
Verily develops AI-powered chronic care management solutions like Lightpath, which provides personalized care for individuals with cardiometabolic conditions, leveraging integrated data to support interventions such as GLP-1s and continuous glucose monitoring.
Public Health Pathogen Tracking
Through their Sightline solutions, Verily provides public-health surveillance and wastewater monitoring services, including high-throughput nucleic-acid assays, analytics, and public dashboards for community-level pathogen monitoring. They partner with governments and communities to detect and mitigate disease at a population level.
Digital Biomarkers & Wearable Sensing
Verily develops hardware, software, and analytics to capture wearable sensor data and convert signals into validated digital measures for research and clinical endpoints. They have developed devices like the Study Watch for continuous monitoring in clinical trials.
Physician Tip

Verily's solutions aim to provide physicians with more personalized, predictive, and precise healthcare tools. Their AI-native platform, Pre, is designed to make healthcare data AI-ready and fit for purpose, enabling advanced analytics and AI deployment directly into care workflows. This can help reduce the time and mental energy spent on manual processes, allowing clinicians more time to focus on patients. The integration of diverse, longitudinal real-world data, including wearable sensor data, can offer a more holistic and dynamic view of a patient's health, leading to earlier and more precise diagnoses and more effective disease management. Furthermore, their chronic care solutions, like Lightpath, combine AI-based technology with clinical experts to provide personalized support for managing conditions like diabetes and obesity. Verily's efforts in digitizing clinical trial protocols with AI can also accelerate research, potentially bringing new treatments to patients faster.

Verily's Pre platform is built on a FHIR-native data model (Syntax™) to ensure interoperability and organize complex health information. They collaborate with NVIDIA to integrate NVIDIA's AI technology stack, including GPUs, the NeMo generative AI framework, Parabricks for genomic analysis, and RAPIDS data science libraries, into the Pre platform to accelerate AI model development and analysis. Verily has also partnered with Samsung to integrate Galaxy Watch sensor data into their Viewpoint Evidence solution for real-world studies, and with Salesforce to integrate the Pre Platform with Agentforce for Health. Their platform works with existing cloud solutions, prioritizing privacy, security, and data governance.

Products by Verily Life Sciences

3 products in the directory

Study Watch with Irregular Pulse Monitor (Home)
Verily Health
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Study Watch
Verily
Cardiology AI
Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Study Watch with Irregular Pulse Monitor
Verily Life Sciences
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor is an FDA-cleared, prescription-only wearable device from Verily Life Sciences. It is designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.

What the Web Says

Verily Life Sciences, an Alphabet company, generally receives mixed to positive reviews. While praised for its innovative mission in healthcare and life sciences, particularly its focus on data-driven solutions and cutting-edge technology, it also faces criticism regarding internal culture, execution challenges, and the practical application of its ambitious projects. Employee reviews often highlight a strong mission but point to issues with management and work-life balance.

Overall: Mixed

Strengths

  • Strong mission-driven company focused on impactful healthcare solutions.
  • Access to cutting-edge technology and resources as an Alphabet company.
  • Talented and intelligent colleagues, fostering a stimulating work environment.
  • Good compensation and benefits package.
  • Potential for significant impact in the healthcare and life sciences industry.
  • Focus on data science and AI in health.

Limitations

  • Frequent reorganizations and shifting priorities leading to instability.
  • Challenges with project execution and bringing products to market effectively.
  • Bureaucracy and slow decision-making processes.
  • Management issues, including lack of clear direction and communication.
  • Work-life balance can be challenging due to high demands and pressure.
  • Internal politics and cultural issues reported by some employees.

Based on reviews from: Glassdoor, Reddit, Healthcare IT News (various articles/discussions), G2 (limited product reviews), Capterra (limited product reviews)

Last updated: 2026-10-18

Videos

News, demos, and interviews about Verily Life Sciences.

Loading videos...

Videos load interactively. If none appear, search YouTube for Verily Life Sciences →

View all on YouTube

Press & Coverage

MedPath Trial
Verily Secures $300 Million Investment and Gains Independence from Alphabet to Advance AI-Driven Precision Health Platform
Verily Life Sciences secured $300 million in funding and is restructuring as an independent corporation, transitioning from an Alphabet subsidiary to a standalone precision health company. This investment, led by Series X Capital, will accelerate its AI-native precision health platform strategy.
2026-03
Verily Newsroom
Verily Health Secures New Investment From NVIDIA and CU Healthcare Innovation Fund
Verily Health Inc. announced new investment support from NVIDIA, extending its March fundraising, with existing investor CU Healthcare Innovation Fund II, LP also making an additional investment. This funding will support the next phase of Verily's precision health AI strategy.
2026-09
Verily Newsroom
Verily and Samsung Collaborate to Accelerate Clinical Research with the Galaxy Watch and Pre Platform
Verily Life Sciences and Samsung Electronics America announced a collaboration to integrate Samsung's Galaxy Watch 8 with Verily's Pre platform. This partnership aims to accelerate clinical research by combining advanced health analytics with consumer-grade wearable data.
2026-03
InterviewPal
Verily Layoffs 2026: 58 Employees Affected in Life Sciences Cuts
Verily, the life sciences technology company, laid off 58 employees in June 2026, representing approximately 4% of its workforce. These cuts reflect ongoing challenges and restructuring in the digital health industry.
2026-06
Verily Newsroom
Verily Health Awarded Centers for Disease Control and Prevention Contract to Support National Infectious Disease Wastewater Surveillance
Verily Health has been awarded a contract by the Centers for Disease Control and Prevention (CDC) to support national infectious disease wastewater surveillance. This highlights Verily's role in public health initiatives.
2026-10
Verily Newsroom
Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program
Verily Health has been selected to build a data platform for the ARPA-H CIRCLE Program, indicating its involvement in significant government-backed healthcare technology initiatives.
2026-10
HIPAA Journal
Alphabet's Verily Sued by Former Executive Over Alleged HIPAA Breaches
A former executive has sued Verily Life Sciences LLC, alleging that the company misused personally identifiable health information of over 25,000 patients and failed to report HIPAA breaches. Verily denies these allegations.
2025-09
MedPath Trial
Verily Shuts Down Medical Device Program as Alphabet Pivots to AI-Driven Healthcare Strategy
Verily, Alphabet's life sciences subsidiary, eliminated its entire medical device program and laid off staff as part of a strategic shift towards an AI and data infrastructure-focused healthcare strategy.
2025-08

Frequently Asked Questions

Verily utilizes AI and advanced analytics to integrate and interpret diverse healthcare data, including genomics, wearables, and electronic health records. This enables the identification of personalized health insights, risk stratification, and the development of more targeted interventions for individual patients, ultimately aiming to improve treatment efficacy and patient outcomes.
Verily offers several platforms relevant to clinical research and real-world evidence, such as Project Baseline, which facilitates observational studies and clinical trials by collecting and organizing health data. Their solutions aim to streamline data collection, harmonize disparate datasets, and generate robust real-world evidence to inform clinical practice and product development.
Verily prioritizes data privacy and security by implementing robust technical and organizational safeguards, adhering to industry best practices, and complying with relevant regulations like HIPAA and GDPR. They employ de-identification and anonymization techniques, strict access controls, and secure data infrastructure to protect sensitive patient information throughout their data lifecycle.
Verily actively seeks partnerships with healthcare systems, pharmaceutical companies, and academic institutions to co-develop and deploy their solutions. These collaborations are crucial for gaining clinical insights, validating technologies in real-world settings, and ensuring that their products are integrated effectively into existing healthcare workflows, thereby accelerating adoption and scalability.
Verily contributes to public health by developing tools for chronic disease management, such as remote monitoring solutions, and by participating in initiatives for pathogen tracking, as seen in some of their COVID-19 related work. For public health administrators, this offers benefits in terms of population health insights and outbreak response, but also raises concerns about data aggregation, privacy at scale, and equitable access to these advanced tools.
Verily's pricing models can vary depending on the specific product or solution, the scale of deployment, and the nature of the partnership, often involving subscription-based fees or project-specific agreements. Healthcare organizations can typically expect comprehensive support, including implementation assistance, technical training, and ongoing customer service to ensure seamless integration and optimal utilization of their platforms.
Verily's long-term vision is to transform healthcare through data-driven insights and precision medicine, continuously investing in R&D for AI model development and digital health solutions. As an Alphabet company, it benefits from significant resources and a stable foundation, aiming to remain at the forefront by fostering innovation, expanding its product portfolio, and forging strategic partnerships to address evolving healthcare needs.

Investors

Who's funded Verily Life Sciences.

Related Companies

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

CureCompanion is a healthcare technology company that specializes in virtual care solutions, offering an integrated platform of hardware and software for telemedicine. Their technology goes beyond basic video conferencing, enabling healthcare providers to conduct comprehensive virtual examinations. This includes the ability to examine skin, eyes, ears, and throat using HD cameras, listen to heart and […]

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.